| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 15, 2026 | Половые трудности | Половые трудности Почему растут продажи гормонов и смежных препаратов
Позднее родительство, развитие вспомогательных репродуктивных технологий (ВРТ), рост интереса мужчин к гормональной терапии и более осознанное отношение женщин к репродук... |
| Jan 23, 2026 | Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more | |
| Oct 1, 2025 | Jim Cramer: Billionaires ‘won’t save you—they’re out for themselves.’ Here are 5 biggest money mistakes ‘I still regret’ today | If picking great companies and buying their stocks seems so simple, why can’t we all make money? Why do so many investors get discouraged or call stocks too risky?
Mistakes, that’s why. We make mistakes and we get defeated. I make mistakes,... |
| Dec 20, 2024 | Ottimo Pharma: A New Dawn in Cancer Treatment with $140 Million Boost | In the world of biotechnology, every dollar counts. Ottimo Pharma, a New York City-based biotech firm, has just raised over $140 million in a Series A funding round. This infusion of capital is not just a financial milestone; it’s a beacon ... |
| Dec 20, 2024 | Ottimo Pharma: Over $140 Million (Series A) Raised To Advance Bifunctional Medicines | Ottimo Pharma – a private biotech company pioneering bifunctional medicines to extend the lives of people with cancer – announced the completion of a Series A financing round of over $140 million. The funding round was led by OrbiMed, Avoro... |
| Sep 19, 2024 | Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer | NAARDEN, The Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative dise... |
| Sep 3, 2024 | Pharmaceutical Market: Trends, Segmentation, and Growth Opportunities | Share
Tweet
Share
Share
Email
In recent years, the pharmaceutical market has witnessed remarkable growth and transformation, driven by technological advancements, evolving consumer needs, and the global push for better healthcare solutions.... |
| Aug 27, 2024 | ENDO ANNOUNCES CEO TRANSITION | Board to Initiate CEO Search Process; Scott Hirsch Appointed as Interim CEO
MALVERN, Pa., Aug. 27, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company"), a diversified specialty pharmaceutical company t... |
| Jun 4, 2024 | Analysis Group Researchers Suggest a Novel Approach to Measuring Real-World Treatment Effectiveness for Irritable Bowel Syndrome with Diarrhea | BOSTON, June 4, 2024 /PRNewswire/ -- Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), have coauthored a study detailing how treatment-free intervals (TFIs) can be an effective surrogate in r... |
| Apr 16, 2024 | Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business Awards | Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business Awards
Jason Provenzano, the Founder and CEO of Makers Nutrition, achieves victory at the 2024 TITAN Business Awards.
NEW YORK, April 16, 2024 /P... |
| Mar 11, 2024 | Global Beauty Devices Market Size Is Valued At $236.77 Bn by 2030: Data Analysis by Experts at Vantage Market Research | Vantage Market Research
Beauty Devices Market Size, Share, Industry Trends, Growth, and Opportunities Analysis by 2030 WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- The Global Beauty Devices Mark... |
| Nov 29, 2022 | Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents | LAVAL, QC / ACCESSWIRE / November 29, 2022 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") has designated 1261229 B.C. Ltd., the entity that directly or indirectly holds 88.7% of the... |
| Nov 3, 2022 | Bausch Health Announces Third-Quarter 2022 Results | Revenues of $2.046 billion, down 3% reported, up 2% organic basis
Third quarter sales improved sequentially, notably Salix, International, and Solta
Successful debt exchange offer reduces debt by $2.5 billion
Company updates full year guida... |
| Jun 24, 2022 | Joe Papa resigns as chair of Bausch Health as billionaire John Paulson takes over | Joe Papa, chair of Bausch Health, officially resigned on Thursday and the board appointed billionaire hedge fund manager John Paulson as the new chair, effective immediately.
John Paulson
The specialty pharma compan... |
| Jun 17, 2022 | Bausch Health Shelves Its Plan for Solta IPO Amid Market Turmoil | Bausch Health said late Thursday that it was suspending plans for the initial public offering of its Solta Medical skin-care unit, citing turbulence in the markets.
Solta attracted “significant investor interest” during the IPO process, Bau... |
| Apr 20, 2022 | Bausch Health Stock Rises After It Gets Help With Its $22.9 Billion Debt | Bausch Health the specialty pharma company, is making progress in tackling its indebtedness.
Bausch (ticker: BHC) said Wednesday that its eye-care unit, Bausch + Lomb, which has filed to go public, is moving forward with plans to add $3 bil... |
| Jan 28, 2022 | Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes | LAVAL, QC, Jan. 27, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced its previously announced offering of $1.0 billion aggregate prin... |
| Jan 27, 2022 | Bausch Health Launches $1 Billion Senior Secured Notes Offering | By Adriano Marchese
Bausch Health Cos. Inc. said Thursday that it plans to raise $1 billion by way of a senior secured notes offering.
The Canadian specialty pharmaceutical company said it will use the proceeds toward the redemption of its ... |
| Jan 27, 2022 | Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes | LAVAL, QC, Jan. 27, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of $1.0 billion aggregate principal amount of new ... |
| Jan 18, 2022 | Bausch Health Announces It Is Seeking To Refinance Its Existing Credit Agreement And Conditional Redemption Of Existing Notes - These Steps Will Enable Bausch + Lomb IPO And Facilitate Full Separation | LAVAL, QB, Jan. 18, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it is seeking to refinance its existing credit agreement (the "Credit Agr... |
| Jan 14, 2022 | Bausch + Lomb’s IPO plans come into focus as BHC prepares to split into three | Bausch + Lomb, a company that started as a small optical goods shop in upstate New York and grew to become a global ophthalmic products business, is returning to the public markets. The company has filed preliminary paperwork for an IPO, a ... |
| Jan 11, 2022 | Bausch Health Will Provide Business And Strategic Update At The 40th Annual J.P. Morgan Healthcare Conference | LAVAL, Quebec, Jan. 11, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") will provide a progress update on its business and strategic initiatives in a published present... |
| Jan 4, 2022 | NEW SURVEY FROM BAUSCH + LOMB AND GLAUCOMA RESEARCH FOUNDATION REVEALS EMOTIONAL AND SOCIAL IMPACT OF HYPEREMIA ON GLAUCOMA PATIENTS | Survey Results Are Released During Glaucoma Awareness Month
LAVAL, Quebec, and SAN FRANCISCO, Jan. 4, 2022 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Hea... |
| Dec 22, 2021 | RELISTOR® (METHYLNALTREXONE BROMIDE) DATA IS PUBLISHED IN THE JOURNAL OF EMERGENCY MEDICINE | Data from a Post-Hoc Analysis Supports the Use of Salix's RELISTOR for Patients with Opioid-Induced Constipation and Advanced Illness in the Emergency Department Setting
LAVAL, QC, Dec. 22, 2021 /PRNewswire/ -- Bausch Health Companies Inc. ... |
| Nov 15, 2021 | Bausch + Lomb Reports More Than 41 Million Units Of Contact Lens, Eye And Lens Care Materials Recycled Through ONE By ONE And Biotrue® Eye Care Recycling Programs | LAVAL, QC and TRENTON, N.J., Nov. 15, 2021 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced its exclusive ONE by ONE and Biotrue... |
| Nov 4, 2021 | Bausch Health Announces Participation In Upcoming Investor Conferences | LAVAL, QC, Nov. 4, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in upcoming investor conferences.
Joseph C. Papa, ... |
| Nov 2, 2021 | Bausch Health Companies Inc. Announces Third-Quarter 2021 Results | LAVAL, Quebec, Nov. 2, 2021 /PRNewswire/ --
Third-Quarter 2021 Financial Results
Revenues of $2.111 Billion
GAAP Net Income of $188 Million
Adjusted EBITDA (non-GAAP)1 of $885 Million
GAAP Cash Generated from Operations of $564 Million
Expe... |
| Nov 2, 2021 | BAUSCH HEALTH COMPANIES INC. ANNOUNCES THIRD-QUARTER 2021 RESULTS - Form 8-K | BAUSCH HEALTH COMPANIES INC. ANNOUNCES THIRD-QUARTER 2021 RESULTS
•Third-Quarter 2021 Financial Results
◦Revenues of $2.111 Billion
◦GAAP Net Income of $188 Million
◦Adjusted EBITDA (non-GAAP)1 of $885 Million
◦GAAP Cash Generated from Oper... |
| Nov 2, 2021 | Bausch Health Third-Quarter 2021 Earnings Presentation | 3Q 21
Financial Results
Forward-LookingStatements
This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but... |
| Oct 27, 2021 | Bausch + Lomb Launches Biotrue® Eye Care Recycling Program in Collaboration With TerraCycle in the United States | All Brands of Eye Drop Single Dose Units, Contact Lens Cases and Contact Lens Solution Caps,* As Well As Biotrue® Hydration Boost Multi-Dose Eye Drop Bottles Can Now Be Recycled
LAVAL, QB and TRENTON, N.J., Oct. 27, 2021 /PRNewswire/ -- Bau... |
| Oct 19, 2021 | Bausch Health : Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology Conference | Eight Poster Presentations Include New Analyses of ARAZLO®, DUOBRII® and SILIQ®
LAVAL, QC, Oct. 19, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest pres... |
| Sep 30, 2021 | Bausch Health : + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial Of NOV03 (perfluorohexyloctane) in Dry Eye Disease Associated with Meibomian Gland Dysfunction | LAVAL, QC and HEIDELBERG, Germany, Sept. 30, 2021 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and Novaliq GmbH ("Novaliq"), a biop... |
| Sep 1, 2021 | Bausch Health Announces Participation In Upcoming Investor Conferences | |
| Sep 1, 2021 | Bausch Health : Announces Participation In Upcoming Investor Conferences | LAVAL, QC, Sept. 1, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in multiple upcoming investor conferences.
Sam El... |
| Aug 3, 2021 | Bausch Health Companies Inc. : Announces Second-Quarter 2021 Results | LAVAL, Quebec, Aug. 3, 2021 /PRNewswire/ --
Second-Quarter 2021 Financial Results
Revenues of $2.100 Billion
GAAP Net Loss of $595 Million
Adjusted EBITDA (non-GAAP)1 of $826 Million
GAAP Cash Generated from Operations of $395 Million
Thoma... |
| Aug 3, 2021 | Bausch Health : Second-Quarter 2021 Earnings Presentation | 2Q 21
Financial Results
Forward-LookingStatements
This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but... |
| Aug 3, 2021 | BAUSCH HEALTH : ANNOUNCES SECOND-QUARTER 2021 RESULTS (Form 8-K) | BAUSCH HEALTH COMPANIES INC. ANNOUNCES SECOND-QUARTER 2021 RESULTS
•Second-Quarter 2021 Financial Results
◦Revenues of $2.100 Billion
◦GAAP Net Loss of $595 Million
◦Adjusted EBITDA (non-GAAP)1 of $826 Million
◦GAAP Cash Generated from Oper... |
| Aug 3, 2021 | Bausch Health : Announces Plans To Pursue An Initial Public Offering Of Solta Medical | IPO Would Unlock Value in a Medical Aesthetics Leader
Transaction Will Enable Bausch Health to Continue to Execute on its Previously Announced Spinoff of its Bausch + Lomb Eye Health Business
LAVAL, QC, Aug. 3, 2021 /PRNewswire/ -- Bausch H... |
| Jul 29, 2021 | Bausch Health : Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients | Scholarships Awarded to Nine Students Affected by Dermatologic Conditions
LAVAL, Quebec, July 29, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescr... |
| Jul 22, 2021 | Bausch Health : Salix Announces 2021 Gastrointestinal Health Scholars Program Winners | LAVAL, Quebec, July 22, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical... |
| Jul 12, 2021 | Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes | |
| Jul 12, 2021 | Bausch Health : + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes | New Preservative-Free and pH-Balanced Products Formulated for Irritated, Dry Eyes
Now Rolling out to Major U.S. Retailers
LAVAL, Quebec, July 12, 2021 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Comp... |
| Jun 23, 2021 | Bausch Health : + Lomb Expands Parameters for + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses | New Parameters Provide a Broader Offering for Presbyopic Patients with Astigmatism
LAVAL, QB, June 23, 2021 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch He... |
| Jun 22, 2021 | Bausch Health : Announces Extension Of Its Tender Offer For Cash Tender Offer For Senior Secured Notes By One Business Day To Reflect The Federal Holiday On June 18, 2021 | LAVAL, QC, June 22, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC)("Bausch Health," the "Company" or the "Offeror") today announced that it has extended the expiration date for its previously... |
| Jun 8, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health : Announces Early Tender Results And Early Settlement Date For Cash Tender Offer For Senior Secured Notes | LAVAL, Quebec, June 7, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health," the "Company" or the "Offeror") announced today the results to date of its pending cash tender offer (t... |
| May 25, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health : Announces Participation At The Jefferies Healthcare Conference | LAVAL, QC, May 25, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that Joseph C. Papa, chairman and chief executive officer; Sam Eldessouky, senior vi... |
| May 25, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health : Announces Pricing Of Private Offering Of Senior Secured Notes | LAVAL, QC, May 24, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced its previously announced offering of $1.6 billion aggregate princ... |
| May 17, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health : Salix Will Feature New Data At Digestive Disease Week® 2021 | TRULANCE® (plecanatide) ePoster Will be Honored as Poster of Distinction
LAVAL, QC, May 17, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceutica... |
| May 17, 2021 | Salix Will Feature New Data At Digestive Disease Week® 2021 | |
| May 6, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health : Announces Participation In Upcoming Investor Conferences | LAVAL, Quebec, May 6, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in multiple upcoming investor conferences.
Jose... |
| May 6, 2021 | Bausch Health Announces Participation In Upcoming Investor Conferences | |
| May 4, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health Companies Inc. : Announces First-Quarter 2021 Results | LAVAL, Quebec, May 4, 2021 /PRNewswire/ --
First-Quarter 2021 Financial Results
Revenues of $2.027 Billion
GAAP Net Loss of $610 Million
Adjusted EBITDA (non-GAAP)1 of $852 Million
GAAP Cash Generated from Operations of $443 Million
Company... |
| May 4, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health : First-Quarter 2021 Earnings Presentation | 1Q 21
Financial Results
Forward-LookingStatements
This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but... |
| Apr 29, 2021 | Bausch Health : + Lomb Will Present New Scientific Data And Analyses On Products And Pipeline Programs During The Association For Research In Vision And Ophthalmology Meeting | One Podium Presentation and 11 Poster Presentations to be Featured
LAVAL, QC, April 29, 2021 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), to... |
| Apr 28, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health : ORTHO DERMATOLOGICS ANNOUNCES STATISTICALLY SIGNIFICANT TOPLINE RESULTS FROM SECOND PIVOTAL PHASE 3 CLINICAL TRIAL EVALUATING IDP-126 GEL IN ACNE VULGARIS | RALEIGH, N.C. - Ortho Dermatologics, one of the largest prescription dermatology health care businesses, announced statistically significant topline results from a second pivotal Phase 3 clinical trial evaluating its investigational medicin... |
| Apr 28, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health : Announces 2021 Annual Meeting of Shareholder Results | LAVAL, Quebec, April 28, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the election of the 13 directors nominated at its 2021 annual meeting of share... |
| Apr 26, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health : Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris | LAVAL, QC - Bausch Health Companies Inc. (NYSE/TSX: BHC) ('Bausch Health') and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced statistically significant topl... |
| Apr 22, 2021 | Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris | |
| Apr 22, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health : Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris | All Three Co-Primary Endpoints Were Achieved
LAVAL, QC, April 22, 2021 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, one of the largest prescription derm... |
| Apr 21, 2021 | Ortho Dermatologics to Present New Data at the 2021 American Academy of Dermatology Annual Meeting | |
| Apr 16, 2021 | Bausch Health Announces VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved In Brazil | |
| Apr 13, 2021 | Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction | |
| Apr 8, 2021 | Bausch Health Launches ENVIVE™ Daily Probiotic Supplement | |
| Apr 8, 2021 | BAUSCH HEALTH COMPANIES INC.
Bausch Health : Launches ENVIVE™ Daily Probiotic Supplement | Proprietary Blend of Five Live Probiotic Strains Shown to Help Reduce Severity and Frequency of Common, Occasional GI Symptoms*
Now Rolling out to Major U.S. Retailers
LAVAL, QC, April 8, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (N... |
| Apr 5, 2021 | Digital health companies raised $6.7B, breaking a record for Q1 | Much of the activity was driven by large, so-called “mega-deals” of $100 million and up. This helped prop up the average deal size from $31.7 million last year to $45.9 million so far in 2021.
In total, the first quarter brought a whopping ... |
| Mar 31, 2021 | Bausch Health sells off Amoun for $740M; Achilles debuts on Nasdaq with $175.5M IPO | Looking to pay down debt ahead of the big Bausch + Lomb spinoff, Bausch Health CEO Joseph Papa has struck a deal to sell one of its units in Egypt for $740 million.
Abu Dhabi-based holding company ADB is handing over the cash for Am... |
| Mar 30, 2021 | Salix Launches GastroHub for Advanced Practice Providers, an Educational Website Designed To Provide Nurse Practitioners and Physician Assistants With Relevant Information for Treating IBS-D and HE | |
| Mar 11, 2021 | Bausch Health Announces CFO Succession Plan | |
| Mar 8, 2021 | Solta Medical Announces the U.S. Launch of The Clear + Brilliant® Touch Laser | |
| Feb 24, 2021 | Bausch Health Announces Agreement With Carl C. Icahn | |
| Feb 24, 2021 | Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2020 Results And Provides 2021 Guidance | |
| Feb 18, 2021 | Salix Announces 2021 Gastrointestinal Health Scholars Program | |
| Feb 16, 2021 | Bausch Health Announces Participation In Upcoming Investor Conferences | |
| Feb 2, 2021 | Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Program | |
| Feb 1, 2021 | Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Age-Related Macular Degeneration (AMD) | |
| Jan 20, 2021 | Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium | |
| Dec 30, 2020 | Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19) | |
| Nov 16, 2020 | Bausch Health Announces Investigational In Vitro Data Indicating Complete Inactivation Of SARS-CoV-2 With LUMIFY® And BESIVANCE® Eye Drops Preserved With Benzalkonium Chloride | |
| Nov 3, 2020 | Bausch Health Companies Inc. Announces Third-Quarter 2020 Results | |
| Oct 29, 2020 | Bausch Health's Rifaximin Receives FDA Orphan Designation For Sickle Cell Disease | |
| Oct 26, 2020 | Ortho Dermatologics To Present New Analyses At The Virtual Fall Clinical Dermatology Conference | |
| Oct 12, 2020 | Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12 | |
| Oct 5, 2020 | Salix Supports Liver Awareness Month With New Educational Initiatives | |
| Sep 23, 2020 | Bausch Health Releases Annual Corporate Social Responsibility Report | |
| Sep 21, 2020 | Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics | |
| Aug 17, 2020 | Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses | |
| Aug 6, 2020 | Bausch Health skyrockets 27% after saying it will spin off its eye-care business | Advertisement
Bausch Health announced on Thursday that it plans to spin off its eye-care business.
Shares of the company skyrocketed as much as 27% in premarket trading Thursday.
The spinoff will result in two companies — the eye care busin... |
| Apr 1, 2020 | Coronavirus Business Tracker: How The Private Sector Is Fighting The Covid-19 Pandemic | Alain Mérieux, founder of BioMérieux.AFP via Getty Images |
| Mar 17, 2020 | Generic ‘identity’ gets lost when companies juggle both generic and brand drugs | We think we know generic drug companies. They challenge patents held by brand firms. They litigate vigorously to overturn those patents. And they often win these challenges.
But what about “generic” companies that play both sides, earning r... |
| Apr 25, 2019 | After Biogen exit, Mitsubishi Tanabe Pharma links up with Salix to develop amiselimod; Two drug developers set up antibiotic collaboration | → About two years after Biogen $BIIB walked away from Mitsubishi Tanabe Pharma‘s MT-1303 (amiselimod), the Japanese drugmaker has joined forces with Bausch Health’s Salix Pharmaceuticals to develop the late-stage oral comp... |
| Aug 8, 2018 | A drug priced out of reach in Africa could save lives from a neglected killer | When it comes to controlling the AIDS pandemic, Botswana is in many ways a model for the world. Last year, the country became one of the first to achieve ambitious United Nations goals for universal access to timely, high-quality treatment ... |
| Sep 2, 2016 | Digital health companies raised almost $224 million in August | Digital health funding in August
So far this year, MobiHealthNews has tracked digital funding that has reached nearly $1.35 billion. August was a healthy month for funding, bringing in $223.86 million across 19 deals, putting it slightly ab... |
| Jul 29, 2016 | Digital health companies raised more than $149M in July | During the month of July, MobiHealthNews reported on 16 digital health companies that raised venture funding. The deals total $149.3 million, which is lower on average when compared to other months this year so far but that's expected for t... |
| Bausch + Lomb’s IPO plans come into focus as BHC prepares to split into three | Bausch + Lomb, a company that started as a small optical goods shop in upstate New York and grew to become a global ophthalmic products business, is returning to the public markets. The company has filed preliminary paperwork for an IPO, a ... |
| A-Rod regrets not investing in Amazon, Microsoft or Starbucks in the ’90s: ‘I wouldn’t have to work so hard today’ | Alex Rodriguez has a few regrets — including not thinking more about the stock market as a young baseball player in Seattle during the 1990s dot-com boom.
“When I was in Seattle — I started in 1993 — I wish I would have just bought a bunch ... |
| Digital health companies raised $6.7B, breaking a record for Q1 | The seemingly-constant stream of funding announcements in March drove digital health funding to a new record.
Startups raised $6.7 billion across 147 deals in the first quarter, according to a new report by Rock Health. And they’ve been rai... |
